INTUITIVE SURGICAL INC 10-K — AI Bull & Bear Analysis

The 2025 10-K reveals a company at a critical juncture, balancing a dominant market position against rising operational costs and legal complexities. While the transition to a recurring revenue model is clearly working, the erosion of gross margins suggests that the cost of maintaining this moat is increasing. The company's ability to leverage its substantial cash reserves to offset these pressures while continuing to innovate remains the central theme for investors. Ultimately, the filing highlights a tension between technological leadership and operational fragility. The success of the da Vinci 5 rollout and the expansion of the Ion platform provide a bullish path forward, but the concentration of manufacturing in Mexico and ongoing antitrust battles introduce significant tail risks that could disrupt the company's compounding growth trajectory.